Literature DB >> 29853715

Impact of the Innovative Medicines Initiative on vaccine development.

Philippe Denoel1, Patricia Londoño-Hayes2, Magda Chlebus3, Magdalena Rodriguez de Azero4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29853715     DOI： 10.1038/nrd.2018.72

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

Review 1.  The ADVANCE Code of Conduct for collaborative vaccine studies.

Authors:  Xavier Kurz; Vincent Bauchau; Patrick Mahy; Steffen Glismann; Lieke Maria van der Aa; François Simondon
Journal:  Vaccine       Date:  2017-03-09       Impact factor: 3.641

2.  Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.

Authors:  Rory D de Vries; Nella J Nieuwkoop; Mark Pronk; Erwin de Bruin; Geert Leroux-Roels; Elisabeth G W Huijskens; Rob S van Binnendijk; Florian Krammer; Marion P G Koopmans; Guus F Rimmelzwaan
Journal:  Vaccine       Date:  2016-11-30       Impact factor: 3.641

3.  A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa.

Authors:  Angela Huttner; Christophe Combescure; Stéphane Grillet; Mariëlle C Haks; Edwin Quinten; Christine Modoux; Selidji Todagbe Agnandji; Jessica Brosnahan; Julie-Anne Dayer; Ali M Harandi; Laurent Kaiser; Donata Medaglini; Tom Monath; Pascale Roux-Lombard; Peter G Kremsner; Tom H M Ottenhoff; Claire-Anne Siegrist
Journal:  Sci Transl Med       Date:  2017-04-12       Impact factor: 17.956

4.  Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans.

Authors:  Fabiana Spensieri; Emilio Siena; Erica Borgogni; Luisanna Zedda; Rocco Cantisani; Nico Chiappini; Francesca Schiavetti; Domenico Rosa; Flora Castellino; Emanuele Montomoli; Caroline L Bodinham; David J Lewis; Duccio Medini; Sylvie Bertholet; Giuseppe Del Giudice
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

5.  Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model.

Authors:  Hans de Graaf; Diane Gbesemete; Andrew R Gorringe; Dimitri A Diavatopoulos; Kent E Kester; Saul N Faust; Robert C Read
Journal:  BMJ Open       Date:  2017-10-11       Impact factor: 2.692
  5 in total
  2 in total

1.  Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium.

Authors:  January Weiner; David J M Lewis; Jeroen Maertzdorf; Hans-Joachim Mollenkopf; Caroline Bodinham; Kat Pizzoferro; Catherine Linley; Aldona Greenwood; Alberto Mantovani; Barbara Bottazzi; Philippe Denoel; Geert Leroux-Roels; Kent E Kester; Ingileif Jonsdottir; Robert van den Berg; Stefan H E Kaufmann; Giuseppe Del Giudice
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

2.  Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by 18F-FDG- and 11C-PBR28-PET/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted Vaccines.

Authors:  Zarni Win; January Weiner Rd; Allan Listanco; Neva Patel; Rohini Sharma; Aldona Greenwood; Jeroen Maertzdorf; Hans-Joachim Mollenkopf; Kat Pizzoferro; Thomas Cole; Caroline L Bodinham; Stefan H E Kaufmann; Philippe Denoel; Giuseppe Del Giudice; David J M Lewis
Journal:  Front Immunol       Date:  2021-02-05       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.